This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Audrey D. Zhang
audreydzhang.bsky.social
did:plc:bifhk5nuhkvr3bkvd5rlah2i
The more I read about the approval of Sarepta's golodirsen (Vyondys 53), the more it boggles the mind. FDA's CRL with big concerns about efficacy, safety, and the lack of precedent eteplirsen confirmatory trial (over which the drug was approved anyway):...
2025-01-24T23:50:13.045Z